Unknown

Dataset Information

0

Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71.


ABSTRACT: Enterovirus A71 (EV-A71) causes major outbreaks of hand, foot, and mouth disease (HFMD) in many countries, most frequently affecting children, and a small proportion of cases may lead to death. Currently, no vaccine is available in most endemic regions, and no licenced treatments for EV-A71 infection are available. Here, we characterize a human monoclonal antibody (HuMAb), E1, by screening a Fab antibody phage library derived from patients who recovered from EV-A71 infection. E1 exhibits strong neutralizing activity against EV-A71 virus in cells. The cryo-electron microscopy (cryo-EM) structures of the EV-A71 virion in complex with E1 Fab fragments demonstrated that E1 recognized an epitope formed by residues in the BC and HI loops of VP1. In a mouse model, E1 effectively protected against lethal EV-A71 challenge in both prophylactic and therapeutic treatment. In particular, E1 significantly reduces virus titers and muscle damage. E1 might represent a potential adjunct to EV-A71 treatment.

SUBMITTER: Chen Z 

PROVIDER: S-EPMC9189450 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71.

Chen Zhe Z   Bao Linlin L   Zhu Bin B   Fu Hua H   Zhu Shuangli S   Ji Tianjiao T   Xue Ying Y   Liu Chuan C   Wang Xurong X   Li Fengdi F   Lv Qi Q   Qi Feifei F   Yu Pin P   Deng Wei W   Xu Wenbo W   Qin Chuan C   Liu Hongrong H   Jin Qi Q  

Science China. Life sciences 20220609 12


Enterovirus A71 (EV-A71) causes major outbreaks of hand, foot, and mouth disease (HFMD) in many countries, most frequently affecting children, and a small proportion of cases may lead to death. Currently, no vaccine is available in most endemic regions, and no licenced treatments for EV-A71 infection are available. Here, we characterize a human monoclonal antibody (HuMAb), E1, by screening a Fab antibody phage library derived from patients who recovered from EV-A71 infection. E1 exhibits strong  ...[more]

Similar Datasets

| S-EPMC8164134 | biostudies-literature
| S-EPMC8395941 | biostudies-literature
| S-EPMC7179613 | biostudies-literature
| S-EPMC7235037 | biostudies-literature
| S-EPMC10298210 | biostudies-literature
| S-EPMC8710476 | biostudies-literature
| S-EPMC4777393 | biostudies-literature
| S-EPMC8880313 | biostudies-literature
| S-EPMC2268459 | biostudies-literature
| S-EPMC4414269 | biostudies-literature